将高血压护理纳入乌干达艾滋病毒差异化服务提供模式的早期发现:一项混合方法研究

IF 4.9 1区 医学 Q2 IMMUNOLOGY
John Baptist Kiggundu, Fred C. Semitala, Chelsea Faith Lipoto, Lilian Giibwa, Robert Twine, Savio Mwaka, Florence Ayebare, Christine Kiwala, Evelyn N. Magambo, Gerald Mutungi, Isaac Ssinabulya, Donna Spiegelman, James Kayima, Martin Muddu, Jeremy I. Schwartz, Anne R. Katahoire, Chris T. Longenecker
{"title":"将高血压护理纳入乌干达艾滋病毒差异化服务提供模式的早期发现:一项混合方法研究","authors":"John Baptist Kiggundu,&nbsp;Fred C. Semitala,&nbsp;Chelsea Faith Lipoto,&nbsp;Lilian Giibwa,&nbsp;Robert Twine,&nbsp;Savio Mwaka,&nbsp;Florence Ayebare,&nbsp;Christine Kiwala,&nbsp;Evelyn N. Magambo,&nbsp;Gerald Mutungi,&nbsp;Isaac Ssinabulya,&nbsp;Donna Spiegelman,&nbsp;James Kayima,&nbsp;Martin Muddu,&nbsp;Jeremy I. Schwartz,&nbsp;Anne R. Katahoire,&nbsp;Chris T. Longenecker","doi":"10.1002/jia2.26499","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Uganda's national guidelines recommend integrated HIV and hypertension care; however, integration of hypertension care into HIV differentiated service delivery (DSD) models has not been extensively described. We aimed to describe trends in DSD models for people living with HIV (PLHIV) with hypertension and to qualitatively describe the experiences of healthcare providers (HCPs) and PLHIV with hypertension after implementing integrated care.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We conducted a parallel convergent mixed methods study nested in an ongoing stepped wedge cluster randomised trial in Kampala and Wakiso districts. Quantitative data (age, sex, blood pressure, DSD model, medication prescriptions) were collected from routine medical records at eight clinics implementing the enhanced care package between March 2023 and July 2024. Additionally, structured interviews were conducted at two clinics with HCPs (<i>n</i> = 6, 3 per clinic) and PLHIV with hypertension (<i>n</i> = 8, 4 per clinic). Our quantitative outcome variable was enrolment in intensive DSD models (facility-based individual and group models) versus other DSDs. A generalised estimation equation was used to account for within clinic correlation and repeated measures within participants over time. Inductive thematic analysis was applied to the qualitative data using the Consolidated Framework for Implementation Research.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Overall, 3164 PLHIV with hypertension accessed care at the eight clinics. Median age was 46 years (IQR 38–56); more than two-thirds were female. There was considerable heterogeneity across clinics in the use of DSD models during the study period. Overall, use of intensive models increased over time (OR 1.127 [1.059−1.199] per month). However, two clinics showed significant time interaction effects (Wald test χ<sup>2</sup> (7) = 69.94, <i>p</i> &lt; 0.001), with a decrease in the intensive models over time. HCPs and PLHIV observed that integrating hypertension care was easily adaptable in some models, while more challenging in others. The availability of resources and synchronisation of HIV and hypertension visits facilitated the integration of hypertension care within the HIV DSD models.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The integration of hypertension management into HIV DSD models is both feasible and adaptable; however, it requires transitioning PLHIV between various models based on clinical needs. To facilitate this process, comprehensive client education by the HCPs is necessary.</p>\n </section>\n \n <section>\n \n <h3> Clinical Trial Number</h3>\n \n <p>clinicaltrials.gov # NCT05609513</p>\n </section>\n </div>","PeriodicalId":201,"journal":{"name":"Journal of the International AIDS Society","volume":"28 S3","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jia2.26499","citationCount":"0","resultStr":"{\"title\":\"Early findings from the integration of hypertension care into differentiated service delivery models for HIV in Uganda: a mixed-method study\",\"authors\":\"John Baptist Kiggundu,&nbsp;Fred C. Semitala,&nbsp;Chelsea Faith Lipoto,&nbsp;Lilian Giibwa,&nbsp;Robert Twine,&nbsp;Savio Mwaka,&nbsp;Florence Ayebare,&nbsp;Christine Kiwala,&nbsp;Evelyn N. Magambo,&nbsp;Gerald Mutungi,&nbsp;Isaac Ssinabulya,&nbsp;Donna Spiegelman,&nbsp;James Kayima,&nbsp;Martin Muddu,&nbsp;Jeremy I. Schwartz,&nbsp;Anne R. Katahoire,&nbsp;Chris T. Longenecker\",\"doi\":\"10.1002/jia2.26499\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>Uganda's national guidelines recommend integrated HIV and hypertension care; however, integration of hypertension care into HIV differentiated service delivery (DSD) models has not been extensively described. We aimed to describe trends in DSD models for people living with HIV (PLHIV) with hypertension and to qualitatively describe the experiences of healthcare providers (HCPs) and PLHIV with hypertension after implementing integrated care.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We conducted a parallel convergent mixed methods study nested in an ongoing stepped wedge cluster randomised trial in Kampala and Wakiso districts. Quantitative data (age, sex, blood pressure, DSD model, medication prescriptions) were collected from routine medical records at eight clinics implementing the enhanced care package between March 2023 and July 2024. Additionally, structured interviews were conducted at two clinics with HCPs (<i>n</i> = 6, 3 per clinic) and PLHIV with hypertension (<i>n</i> = 8, 4 per clinic). Our quantitative outcome variable was enrolment in intensive DSD models (facility-based individual and group models) versus other DSDs. A generalised estimation equation was used to account for within clinic correlation and repeated measures within participants over time. Inductive thematic analysis was applied to the qualitative data using the Consolidated Framework for Implementation Research.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Overall, 3164 PLHIV with hypertension accessed care at the eight clinics. Median age was 46 years (IQR 38–56); more than two-thirds were female. There was considerable heterogeneity across clinics in the use of DSD models during the study period. Overall, use of intensive models increased over time (OR 1.127 [1.059−1.199] per month). However, two clinics showed significant time interaction effects (Wald test χ<sup>2</sup> (7) = 69.94, <i>p</i> &lt; 0.001), with a decrease in the intensive models over time. HCPs and PLHIV observed that integrating hypertension care was easily adaptable in some models, while more challenging in others. The availability of resources and synchronisation of HIV and hypertension visits facilitated the integration of hypertension care within the HIV DSD models.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>The integration of hypertension management into HIV DSD models is both feasible and adaptable; however, it requires transitioning PLHIV between various models based on clinical needs. To facilitate this process, comprehensive client education by the HCPs is necessary.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Clinical Trial Number</h3>\\n \\n <p>clinicaltrials.gov # NCT05609513</p>\\n </section>\\n </div>\",\"PeriodicalId\":201,\"journal\":{\"name\":\"Journal of the International AIDS Society\",\"volume\":\"28 S3\",\"pages\":\"\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jia2.26499\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the International AIDS Society\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jia2.26499\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International AIDS Society","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jia2.26499","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

乌干达国家指南建议艾滋病毒和高血压综合护理;然而,将高血压护理纳入艾滋病毒差异化服务提供(DSD)模型尚未得到广泛描述。我们的目的是描述患有高血压的HIV感染者(PLHIV)的DSD模型的趋势,并定性地描述医疗保健提供者(HCPs)和高血压的PLHIV患者在实施综合护理后的经验。我们在坎帕拉和瓦基索地区进行了一项正在进行的阶梯楔形聚类随机试验,并进行了平行收敛混合方法研究。定量数据(年龄、性别、血压、DSD模型、药物处方)收集自2023年3月至2024年7月期间实施强化护理一揽子计划的8家诊所的常规医疗记录。此外,在两个有HCPs(每个诊所n = 6,3)和PLHIV合并高血压(每个诊所n = 8,4)的诊所进行了结构化访谈。我们的定量结果变量是密集DSD模型(基于设施的个体和群体模型)与其他DSD的入组情况。一个广义的估计方程被用来解释临床内的相关性,并随着时间的推移在参与者中重复测量。采用实施研究综合框架对定性数据进行归纳专题分析。结果共有3164例高血压患者在8家诊所就诊。中位年龄46岁(IQR 38-56);其中超过三分之二是女性。在研究期间,各个诊所在使用DSD模型方面存在相当大的异质性。总体而言,密集模型的使用随着时间的推移而增加(OR为每月1.127[1.059−1.199])。但两家诊所均存在显著的时间交互效应(Wald检验χ2 (7) = 69.94, p <;0.001),密集模型随着时间的推移而减少。HCPs和PLHIV观察到,整合高血压护理在一些模式中很容易适应,而在另一些模式中则更具挑战性。资源的可用性和艾滋病毒和高血压就诊的同步性促进了艾滋病毒DSD模型中高血压护理的整合。结论将高血压管理纳入HIV DSD模型具有可行性和适应性;然而,它需要根据临床需要在各种模型之间进行转换。为了促进这一过程,HCPs对客户进行全面的教育是必要的。临床试验编号clinicaltrials.gov # NCT05609513
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Early findings from the integration of hypertension care into differentiated service delivery models for HIV in Uganda: a mixed-method study

Early findings from the integration of hypertension care into differentiated service delivery models for HIV in Uganda: a mixed-method study

Introduction

Uganda's national guidelines recommend integrated HIV and hypertension care; however, integration of hypertension care into HIV differentiated service delivery (DSD) models has not been extensively described. We aimed to describe trends in DSD models for people living with HIV (PLHIV) with hypertension and to qualitatively describe the experiences of healthcare providers (HCPs) and PLHIV with hypertension after implementing integrated care.

Methods

We conducted a parallel convergent mixed methods study nested in an ongoing stepped wedge cluster randomised trial in Kampala and Wakiso districts. Quantitative data (age, sex, blood pressure, DSD model, medication prescriptions) were collected from routine medical records at eight clinics implementing the enhanced care package between March 2023 and July 2024. Additionally, structured interviews were conducted at two clinics with HCPs (n = 6, 3 per clinic) and PLHIV with hypertension (n = 8, 4 per clinic). Our quantitative outcome variable was enrolment in intensive DSD models (facility-based individual and group models) versus other DSDs. A generalised estimation equation was used to account for within clinic correlation and repeated measures within participants over time. Inductive thematic analysis was applied to the qualitative data using the Consolidated Framework for Implementation Research.

Results

Overall, 3164 PLHIV with hypertension accessed care at the eight clinics. Median age was 46 years (IQR 38–56); more than two-thirds were female. There was considerable heterogeneity across clinics in the use of DSD models during the study period. Overall, use of intensive models increased over time (OR 1.127 [1.059−1.199] per month). However, two clinics showed significant time interaction effects (Wald test χ2 (7) = 69.94, p < 0.001), with a decrease in the intensive models over time. HCPs and PLHIV observed that integrating hypertension care was easily adaptable in some models, while more challenging in others. The availability of resources and synchronisation of HIV and hypertension visits facilitated the integration of hypertension care within the HIV DSD models.

Conclusions

The integration of hypertension management into HIV DSD models is both feasible and adaptable; however, it requires transitioning PLHIV between various models based on clinical needs. To facilitate this process, comprehensive client education by the HCPs is necessary.

Clinical Trial Number

clinicaltrials.gov # NCT05609513

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of the International AIDS Society
Journal of the International AIDS Society IMMUNOLOGY-INFECTIOUS DISEASES
CiteScore
8.60
自引率
10.00%
发文量
186
审稿时长
>12 weeks
期刊介绍: The Journal of the International AIDS Society (JIAS) is a peer-reviewed and Open Access journal for the generation and dissemination of evidence from a wide range of disciplines: basic and biomedical sciences; behavioural sciences; epidemiology; clinical sciences; health economics and health policy; operations research and implementation sciences; and social sciences and humanities. Submission of HIV research carried out in low- and middle-income countries is strongly encouraged.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信